Drugs / PSC-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04043819 | Sep 2019 → Jan 2021 | osteoarthritis, knee | Personalized Stem Cells, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PSC-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04043819 ↗ |
| Modality | Cell therapy | “PSC-01 is a form of autologous cellular therapy” NCT04043819 ↗ |